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Abstract
BioProspecting is a novel approach that enabled our team to mine data related to genetic markers
from the New England Journal of Medicine (NEJM) utilizing SNOMED CT and the Human Gene
Onotology (HUGO). The Biomedical Informatics Research Collaborative was able to link genes
and disorders using the Multi-threaded Clinical Vocabulary Server (MCVS) and natural language
processing engine, whose output creates an ontology-network using the semantic encodings of the
literature that is organized by these two terminologies. We identified relationships between (genes
or proteins) and (diseases or drugs) as linked by metabolic functions and identified potentially novel
functional relationships between, for example, genes and diseases (e.g. Article #1 ([Gene - IL27] =
> {Enzyme - Dipeptidyl Carboxypeptidase 1}) and Article #2 ({Enzyme - Dipeptidyl
Carboxypeptidase 1} < = [Disorder - Type II DM]) showing a metabolic link between IL27 and Type
II DM). In this manuscript we describe our method for developing the database and its content as
well as its potential to assist in the discovery of novel markers and drugs.
Background
"The best way to predict the future, is to create it" – Peter 
Drucker, Harvard University
The Bioinformatics and Genomics communities have had
great success in the past several years in the discovery of
the genetic basis of Mendelian disorders [1]. This success
has been achieved mainly via the use of computing tools
delivered by the field of Bioinformatics [2]. The bioinfor-
matics research community employs technology, and
pathological and genetic standards to assist in the linkage
of genes and disorders [2]. Unfortunately, many diseases
are not easily traced to a single genetic variation and the
true origin of a disease is a complex interplay of genetic
variations, environmental factors, "lifestyle" characteris-
tics, with some stochastic processes [3].
To advance medical science and healthcare, a broader
understanding of genetic markers and their relationships
to each other is needed [4]. Our project was an attempt to
"discover" markers and later research, linkages between
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erature.
"It is the responsibility of those of us involved in today's biomed-
ical research enterprise to translate the remarkable scientific
innovations we are witnessing into health gains for the nation.
... What novel approaches can be developed that have the
potential to be truly transforming for human health? [5] Elias
Zerhouni, M.D., 2005
NEJM
The New England Journal of Medicine is widely consid-
ered one of the most influencial peer-reviewed medical
journals in the world [6]. It is the oldest continuously
published medical journal. The journal was inaugurated
in 1812 as the New England Journal of Medicine and Sur-
gery [7]. In 1928 the NEJM took on its present name after
one hundred years as The Boston Medical and Surgical
Journal.
The website for the George Polk Award noted in its 1977
award that the New England Journal of Medicine "provided
the first significant mainstream visibility for a publication
that would achieve enormous attention and prestige in
the ensuing decades." [8]
The journal publishes widely cited editorials, papers on
original research, review articles, correspondences and
case reports. The journal consistently has the highest
impact factor of the journals of clinical medicine (includ-
ing the Journal of the American Medical Association, and The
Lancet); in 2006, the impact factor was 51 and according
to "Journal Citation Reports" was the first research journal
to surpass 50.
The NEJM provides on-line (electronic) access dating back
to 1994. Our study utilized all electronic data for the
27,000 on-line articles published from January 1994
through December 2006.
SNOMED CT (Systematized Nomenclature of Medicine)
SNOMED CT (SCT) is a large-scale ontology used for the
description of current medical and health community
knowledge [9]. We utilized SCT due to its value for the
functional purposes of computation from the medical lit-
erature and the issues related to maintaining and deliver-
ing it for those purposes. SCT is maintained by the College
of American Pathologists (CAP) and is designed to repre-
sent all health and medical domains. Although very broad
with over 360,000 concepts and 1.2 million relations it
does not provide complete coverage of all medical con-
tent. The SCT modeling has been performed over more
than a forty-year period and in the late 1990s SNOMED
RT was merged with another large ontology, the Reed
codes v3, developed in the United Kingdom.
Ontologies, to be useful for computation for practical
tasks, need to be precise in two ways; firstly, they need to
Table 2: Links between drugs and disorders through a metabolic function
DISTINCT (Drug-Disorder) DISTINCT (TERM1) DISTINCT (TERM2)
DRUG-DISORDER (11,312,477) DRUGS (1,783) DISORDER (8,076)
Protein-Disorder Protein Disorder
PROTEIN [41175001] – DISORDER (5,576,445) PROTEIN [41175001] (890) DISORDER (8,076)
PROTEIN [61321005] – DISORDER (144,741) PROTEIN [61321005] (24) DISORDER (8,057)
PROTEIN [88878007] – DISORDER (5,694,011) PROTEIN [88818007] (878) DISORDER (8,076)
Total – 11,415,197
Table 1: Links between genes and disorders through a metabolic function
DISTINCT (Gene-Disorder Pairs) DISTINCT (Gene) DISTINCT (Disorder)
GENE [HUGO HGNC Database] – DISORDER (14,293,089) GENE [HUGO] (2,244) DISORDER (8,076)
GENE [20889005] – DISORER (16,135) GENE [20889005] (3) DISORDER (7,728)
GENE [67271001] – DISORDER (151,329) GENE [67271001] (24) DISORDER (8,064)
GENE [8116006] – DISORDER (72,082) GENE [8116006] (13) DISORDER (8,059)
Total - 14,532,635Page 2 of 8
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ural world we wish to deal in. Ontologies need to be accu-
rate and closely follow human understanding otherwise
they create confusion in their design and their use. This
means the ontology needs to be constructed with very
close attention to the meanings of the terms used in it.
Hence the names used in the ontology need to represent
closely the understanding we have of the real world [10].
Secondly the variety of linguistic "usage" of those terms
needs to be explored to uncover the diversity of semantic
roles of the terms and ensure that only those roles that are
useful are included in the ontological modeling, and to
remove ambiguity in the use of those roles. Precision of
definition is particularly important in establishing the
relationships between elements and identifying the fun-
damental atomic elements and how they combine or "fit
together" systematically to form compositional expres-
sions. Ontologies also consist of abstractions with each
level of the ontology being more abstract as one moves up
the hierarchy. This structure allows us to talk about the
world at the different levels of abstraction we would expe-
rience outside the realm of the "machine". In using ontol-
ogy for computation there are two basic forms of
abstraction available, aggregation and generalization.
Generalization hierarchies are used throughout SCT as the
basic mechanisms for relating content. Aggregation hier-
archies on the other hand have not been used properly but
rather transposed so that they appear like generalization
hierarchies.
SCT provides coverage for diagnoses, findings, procedures
and testing. In one study SCT provided 92.3% coverage of
common medical problems seen at the Mayo Clinic [11].
It has been used in subsequent studies for electronic qual-
ity monitoring.[12]
HUGO
The Human Genome Organisation (HUGO) is an organ-
ization involved in the Human Genome Project, a project
about mapping the human genome. HUGO was estab-
lished in 1989 as an international organization, primarily
to foster collaboration between genome scientists around
the world. The HUGO Gene Nomenclature Committee
(HGNC) is one of HUGO's committees and it aims to
assign a unique gene name and symbol to each human
gene.
Results
Novel Relationships
There are 574 metabolic functions that were used to link
to Genes, Proteins, Disorders, and Drugs. See Tables 1, 2,
3, 4, 5
We identified 468,371,305 relationships within the
27,000 NEJM full text articles available online from the
Massachusetts Medical Society. The dates of the articles
ranged from 1994 to 2006. Of these over 54 million
(11.7%) were potentially novel relationships, having
never been mentioned together in any one NEJM article
and over 413 million were previously known. Of the over
66 million relationships identified between Genes and
Diseases, over 14 million (21.9%) were potentially novel.
This degree of novelty represents a powerful opportunity
to capitalize on synergies between articles in the medical
literature. Additionally, should we "encode" other elec-
Table 4: Links between genes and drugs through a metabolic function
DISTINCT (TERM1-TERM2 DISTINCT(TERM1) DISTINCT (TERM2)
GENE [HGNC]-DRUG (3,314,327) GENE [HUGO] (2,244) DRUG (1,783)
GENE [20889005]-DRUG (3,709) GENE [20889005] (3) DRUG (1,749)
GENE [67271001]-DRUG (35,274) GENE [67271001] (24) DRUG (1,782)
GENE [8116006]-DRUG (15,931) GENE [8116006] (13) DRUG (1,782)
Total – 3,369,241
Grand Total – 54,664,445
Known relationships identified within NEJM articles
Table 3: Links between proteins and drugs through a metabolic function
Protein-Drug Protein Drug
PROTEIN [41175001] – DRUG (1,270,905) PROTEIN [41175001] (890) DRUG (1,783)
PROTEIN [61321005] – DRUG (33,652) PROTEIN [61321005] (24) DRUG (1,780)
PROTEIN [88878007] – DRUG (1,315,141) PROTEIN [88818007] (878) DRUG (1,783)
Total – 14,034,895Page 3 of 8
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introduce them into the broader universe of medical liter-
ature the benefits are expected to be even greater.
An example of two articles that "synergized" to link the
"Fyn" gene with Myocarditis using their common associa-
tion with kinase activity were:
Predicting Progression – ZAP-70 in CLL
Terry J. Hamblin, M.D.
"In T-cell signaling, collaboration between ZAP-70 and the
other Src kinases, Lck and Fyn, leads to the activation of down-
stream signaling pathways, including nuclear factor ...κB and
mitogen-associated protein kinase, leading to cellular prolifera-
tion."
Which linked with:
Novel Role for Integrin-Linked Kinase in Modulation of
Coxsackievirus B3 Replication and Virus-Induced Cardio-
myocyte Injury
Mitra Esfandiarei, Agripina Suarez, Ansel Amaral, Xiaoning
Si, Maziar Rahmani, Shoukat Dedhar, Bruce M. McManus
'Recently, more consideration has been given to the role of sig-
naling pathways in pathogenesis of enteroviral myocarditis,
providing new platform for identifying a new potential thera-
peutic target for this, so far, incurable disease.".... "Here, we
report on regulation of virus-induced Akt activation by the
integrin-linked kinasein infected mouse cardiomyocytesand
HeLa cells."
Figure 1 shows the connection between the Fyn gene and
Myocarditis based on their connection to Tyrosine Kinase
which is serving as a metabolic function associated with
both the disease and the gene. The figure shows the dis-
ease hierarchy for Cardiovascular diseases from SNOMED
CT.
One could also envision the process as shown in figure 2.
Conclusion
The medical literature is a vast repository of biomedical
knowledge. Much of the richness of this resource is not in
a form that is easily amenable to computational analysis.
Add to this the fact that no medical professional can read
all of the medical literature and Natural language process-
ing has the potential to unlock the knowledge within the
medical literature. In this experiment we used the infor-
mation from the NEJM, one of the premier medical jour-
nals, to determine if novel relationships could be
Illustrates the application parsing two journal articles, tying them to a common metabolic functi n and then "linking" the wo ar icles togetherFigu e 2
Illustrates the application parsing two journal articles, tying 
them to a common metabolic function and then "linking" the 
two articles together.
LBI
Marker Discover
Application
1.
2.
Table 5: Summary data including novel and non-novel links
BASE ON DISTINCT (TERM1 – FUNCTION – TERM2)
DRUG_DISORDER (115,602,787)
GENE_DISORDER (51,833,042)
GENE_DRUG (5,831,303)
PROTEIN_DISORDER (213,884,964)
PROTEIN_DRUG (26,554,764)
Total 413,706,860
NMR study of the SH3 domain from FYN proto-oncogene tyrosine kinase complexed w th the synthetic peptide P2L corresponding to residu s 91–104 of the P85 subunit of the PI3-k ase, f mily of 25 structures [13]Figure 1
NMR study of the SH3 domain from FYN proto-oncogene 
tyrosine kinase complexed with the synthetic peptide P2L 
corresponding to residues 91–104 of the P85 subunit of the 
PI3-kinase, family of 25 structures. [13]Page 4 of 8
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These relationships are indeed prevalent and hold the
potential to increase our understanding of human disease.
The validation by example is illustrated in the identifica-
tion of a gene "FYN" identified in tissue as a marker for
Giant Cell Myocarditis, which was identified also in our
database and would have been available from previous lit-
erature a full two-years in advance of its identification in
tissue and publication. The database not only identified
the relationship of the "FYN" gene to Giant Cell Myocar-
ditis but also to Viral Myocarditis which would have oth-
erwise been considered "not known". Identification of
new relationships that have been validated in tissue is just
one form of validation of the content of the database. We
are currently looking at all of the genes related to more
than three cancers. In this analysis we have identified 10
genes related to thirty or more cancers, 72 genes related to
twenty or more cancers and 191 genes related to ten or
more cancers. Perhaps the common basis for transforma-
This screen depicts genes with a functional relationship to Type 2 Diabetes MellitusFigure 3
This screen depicts genes with a functional relationship to Type 2 Diabetes Mellitus. Clicking on the Gene searches pubmed 
with the gene name. Clicking on the disease name searches the Online Mendelian Inheritance of Man (OMIM) for that disease. 
Clicking on the function brings up the list of functions that link the Gene indicated with that Disorder of Interest (See Figure 4).Page 5 of 8
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but remains "hidden" within the vast amounts of biomed-
ical literature.
Biomedical Informatics has the potential to help us to dis-
cover novel genetic linkage to human disease. This can
lead to benefits in patient care with more rapid knowledge
discovery and translational research empowering clinical
implementation of personalized/individualized medi-
cine.
Methods
We parsed the full-text content of the New England Jour-
nal of Medicine (1994–2006) using our Multi-threaded
Clinical Vocabulary Server (MCVS). The output of this
technology creates an ontology-network using the seman-
tic encodings of the literature that is organized by section
of the article. In this effort we utilized a single Dell 2650
server with 8 GB of main memory and two processors. The
configuration took one year to accomplish, but could
have been done in 1/2 the time with two server and a
quarter of the time with 4. The software is configured so
that this scheme could continue indefinitely.
The indexing was done utilizing SNOMED-CT and the
HUGO Ontologies. This provides robust indexing as
SNOMED-CT has >370,000 concepts and >1,000,000
terms (in our lab we add another 790,000 terms to
improve its clinical relevance) and HUGO has >26,000
human gene names. This concept based indexing repre-
sents a broad and consistent data infrastructure across
articles from the literature.
This screen shows the gene IL27 linked to the Disorder Diabetes Mellitus by metabolic functions such as Dipeptidyl carbox-ypeptidas  IFigure 4
This screen shows the gene IL27 linked to the Disorder Diabetes Mellitus by metabolic functions such as Dipeptidyl carbox-
ypeptidase I.Page 6 of 8
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proteins and functions, diseases and functions and drugs
and functions. Next, we matched these data sets across
function, identifying functional relationships between
proteins and diseases, for example. Further functional
relationships were developed between genes and diseases,
proteins and drugs, genes and drugs, and drugs and dis-
eases. Next, we identified the disjoint sets where, for
example, a gene and a disease match across function but
have not been mentioned together in any previous NEJM
journal article. Our goal was to identify synergy between
articles within the literature indicating potential relation-
ships between genes or proteins and drugs or diseases that
have heretofore not been previously recognized. The data-
base is searchable in all aspects such that a disease-ori-
ented researcher could search the disease they are
interested in and find all of the genes, proteins and drugs
associated with that disease organized by function.
Researchers could either access this information regarding
known synergies (where the gene and disease have been
mentioned in the same article) that verifies the utility of
the algorithm or discontinuities (where the gene and dis-
ease have a functional relationship, however the two enti-
ties have never previously been mentioned in the same
Journal Article). This may indicate the possibility of a
novel relationship that can then be taken back to the
bench for further definition, identification and research.
Proteins and drugs, for example, that have a functional
relationship but that have never been recognized to affect
one another, may be substrate for further basic science
analysis thereby leading to more rapid marker and treat-
ment discovery. We see this as a potential method for
improving the research productivity.
This program/exercise aims to support the development
of novel clinical and translational methods that can
encompass a wide range of techniques including new
methods of phenotyping where one could use SNOMED
CT to phenotype the patients described in this paper. New
biomarkers for research are a potential output of this
project (See Figure 1). This project may also benefit clini-
cal informatics for longitudinal studies that aim to rapidly
look at specific associations that may lead to either addi-
tional retrospective analysis or prospective clinical trials.
The special deliverables of this project are also an interface
where one can search the already recognized (concordant)
relationships, and also disjoint or previously undocu-
mented relationships between genes or proteins and
drugs or diseases (See Figure 1). Free text searching will be
available based on a gene, protein, disease, drug or func-
tion (See Figure 2). As organizing concepts are included,
searching for classes (e.g. concepts like beta blockers for
drugs or cardiovascular diseases) will be possible without
having to articulate the individual sub-classes of informa-
tion. See figures 3 and 4.
Should this "bear fruit" using the New England Journal of
Medicine, other journals such as Science, Nature and Cell
could be added to the corpora. The current collection
holds the New England Journal of Medicine full text col-
lection of over 27,000 articles. We did not survey the Sci-
ence, Nature and Cell collections for an estimate of the
addition to the collection, but we expect significant qual-
ity increases with the addition of these collections.
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